Portugal, June 17 -- Portugal based TAKEDA-Farmaceuticos Portugal, Lda has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491-BRENTUXIMAB VEDOTINA [50 MG; PO CONC SOL INJ; FRS] (B539). The value of the contract is worth 13601100 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....